Cargando…

Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients

SIMPLE SUMMARY: A multispecialty discussion may represent a benefit for cancer patients in receiving the most updated pathway of cure. The aim of this study was to describe the activity of our multidisciplinary team (MDT) meeting on patients with colorectal liver metastases (CRLMs). Information abou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milana, Flavio, Famularo, Simone, Luberto, Antonio, Rimassa, Lorenza, Scorsetti, Marta, Comito, Tiziana, Pressiani, Tiziana, Franzese, Ciro, Poretti, Dario, Di Tommaso, Luca, Personeni, Nicola, Rodari, Marcello, Pedicini, Vittorio, Donadon, Matteo, Torzilli, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405848/ https://www.ncbi.nlm.nih.gov/pubmed/36010944 http://dx.doi.org/10.3390/cancers14163952

Ejemplares similares

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
por: Personeni, Nicola, et al.
Publicado: (2018)

Targeted agents for second-line treatment of advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2019)

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights
por: Cammarota, Antonella, et al.
Publicado: (2022)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
por: Milana, Flavio, et al.
Publicado: (2023)

Advancing prognostic precision in hepatocellular carcinoma: a paradigm shift towards machine learning
por: Milana, Flavio, et al.
Publicado: (2023)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
por: Zanuso, Valentina, et al.
Publicado: (2023)

Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy
por: Famularo, Simone, et al.
Publicado: (2023)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
por: Scorsetti, Marta, et al.
Publicado: (2018)

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
por: Cozzi, Luca, et al.
Publicado: (2020)

Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment
por: Franzese, Ciro, et al.
Publicado: (2021)

How Much Is Enough? A Surgical Perspective on Imaging Modalities to Estimate Function and Volume of the Future Liver Remnant before Hepatic Resection
por: Milana, Flavio, et al.
Publicado: (2023)

Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center
por: Lleo, Ana, et al.
Publicado: (2021)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent
por: Famularo, Simone, et al.
Publicado: (2023)

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)
por: Comito, Tiziana, et al.
Publicado: (2023)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization
por: Lanza, Ezio, et al.
Publicado: (2020)

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment
por: Personeni, Nicola, et al.
Publicado: (2022)

Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
por: Franzese, Ciro, et al.
Publicado: (2017)

Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
por: Loi, Mauro, et al.
Publicado: (2020)

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
por: Comito, Tiziana, et al.
Publicado: (2014)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
por: Ghidini, Michele, et al.
Publicado: (2015)

Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study
por: Personeni, Nicola, et al.
Publicado: (2022)

A Novel CT to Cone-Beam CT Registration Method Enables Immediate Real-Time Intraprocedural Three-Dimensional Assessment of Ablative Treatments of Liver Malignancies
por: Solbiati, Marco, et al.
Publicado: (2018)

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience
por: Tozzi, Angelo, et al.
Publicado: (2013)

Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients
por: Franceschini, Davide, et al.
Publicado: (2022)

Prognostic Value of Metabolic Imaging Data of (11)C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
por: Donadon, Matteo, et al.
Publicado: (2021)

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy
por: Cozzi, Luca, et al.
Publicado: (2017)

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
por: Campani, Claudia, et al.
Publicado: (2020)

847. Trends in Stenotrophomonas maltophilia Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)

Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites
por: Vigano, Luca, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial
por: Franceschini, Davide, et al.
Publicado: (2022)

Stereotactic radiation therapy for oligometastatic esophagogastric adenocarcinoma: outcome and prognostic factors
por: Franceschini, Davide, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0vfjtt52b8hj17nl14i569jp5